Gene: The lldD gene (b3605, JW3580) is part of the lldPRD operon, which includes lldP (permease), lldD (dehydrogenase), and lldR (regulatory protein) .
Protein: The recombinant lldD enzyme is a 45.3 kDa polypeptide with a 24-amino acid His-tag for purification. It contains 420 amino acids (1–396) and is non-glycosylated .
Active Site: Utilizes FMN (flavin mononucleotide) as a cofactor, enabling redox reactions between pyruvate and L-lactate .
Property | Value | Source |
---|---|---|
Molecular Weight | 45.3 kDa | |
Amino Acid Sequence | MGSSHHHHHH... (full sequence in ) | |
Optimal pH | 8.0 | |
Expression System | E. coli (recombinant) |
Engineered E. coli strains overexpressing lldD from Bacillus coagulans (e.g., strain 090B3) achieve high L-lactate yields:
Production Yield: 142.2 g/L L-lactate under temperature-shifting fermentation (37°C growth, 42°C production) .
By-Products: Minimal acetate, pyruvate, or succinate (<1.2 g/L) due to optimized metabolic flux .
Under anaerobic conditions, lldD enables E. coli to oxidize L-lactate to pyruvate, feeding into energy-generating pathways (e.g., TCA cycle) .
LldR regulates the lldPRD operon via a dual role:
Repressor: Binds to operator sites O1 and O2, inhibiting transcription in the absence of L-lactate .
Activator: L-Lactate induces a conformational change in LldR, disrupting DNA looping and enabling transcription .
ArcAB Two-Component System: Activates lldPRD under anaerobic conditions .
PdhR: Pyruvate-sensing transcription factor indirectly modulates lactate metabolism .
Thermodynamic Optimization: Engineered lldD variants (e.g., from Lactobacillus or Streptobacillus) improve L-lactate production by shifting equilibrium toward lactate synthesis .
Acid Resistance: LldR regulates genes for glutamate-dependent acid resistance (e.g., gadW, gadY) and membrane lipid remodeling (e.g., lpxP) .
LldD-containing operons are conserved across E. coli, Cupriavidus, and Pseudomonas spp., enabling lactate-responsive genetic circuits for synthetic biology .
Catalytic Activity: Oxidizes hydroxybutyrate (alternative substrate) and reduces pyruvate to L-lactate .
Purification: Recombinant lldD is purified via affinity chromatography (His-tag) and stored in Tris-HCl buffer with glycerol/DTT .
The lldPRD operon (including lldD) is regulated by:
LldR: A lactate-responsive transcription factor that activates lldPRD in the presence of L-/D-lactate .
ArcAB: A two-component system that represses lldPRD under anaerobic conditions .
Methodological approaches:
Perform electrophoretic mobility shift assays (EMSAs) with purified LldR protein and the lldP promoter region .
Use reporter plasmids (e.g., lacZ fusions) to quantify promoter activity in ΔlldR or ΔarcB mutants .
Conduct chromatin immunoprecipitation (ChIP) to confirm in vivo binding of LldR to the lldPRD operon .
Discrepancies may stem from:
Strain-specific variations: Wild-type vs. engineered strains (e.g., lactate-overproducing mutants) .
Carbon source availability: lldD is constitutively expressed at low levels but strongly induced by lactate .
Resolution strategies:
Compare transcript levels (via RNA-seq) in E. coli K-12 vs. metabolic engineering strains like B0013-070 .
Test induction kinetics using lactate analogs (e.g., glycolate) to rule out cross-regulation .
Thermodynamic limitations: l-iLDH activity is temperature-sensitive. Strains expressing thermophilic L-LDH variants show improved lactate yields at 42°C .
By-product accumulation: Competing pathways (e.g., acetate synthesis) require knockout of pta-ackA or poxB .
Optimization workflow:
Introduce a temperature-inducible promoter (e.g., λpL/pR) to decouple growth (37°C) and production (42°C) phases .
Use flux balance analysis (FBA) to predict optimal gene knockout targets .
LldR (regulator of lldPRD) co-activates glutamate-dependent acid resistance genes (e.g., gadE), enabling survival under lactic acid stress .
Experimental validation:
Perform lactic acid tolerance assays comparing wild-type and ΔlldR strains .
Measure intracellular pH using pH-sensitive fluorescent dyes (e.g., BCECF-AM) in lactate-challenged cells .
Key finding:
Strain | Viability (%) at 120 mM L-lactate |
---|---|
Wild-type | 78 ± 5 |
ΔlldR | 32 ± 4 |
Genomic SELEX (gSELEX): Identifies all LldR-binding sites genome-wide, revealing novel targets like membrane lipid biosynthesis genes .
CRISPRi-based repression: Silences lldD to study its metabolic interactions with central carbon metabolism .
Integration with multi-omics:
To enable E. coli to produce L-lactate, scientists have employed genetic engineering techniques. This involves cloning and expressing L-lactate dehydrogenase genes from different bacteria into E. coli. The process typically includes the following steps :
Recombinant L-LDH produced in E. coli is a single, non-glycosylated polypeptide chain. It typically contains 420 amino acids and has a molecular mass of approximately 45.3 kDa. The recombinant enzyme is often fused with a His-tag at the N-terminus to facilitate purification using chromatographic techniques .
The production of L-lactate using engineered E. coli has significant biotechnological applications. L-lactic acid is an important chiral molecule used in various industries, including food, pharmaceuticals, and biodegradable plastics. The ability to produce L-lactate efficiently through microbial fermentation offers a sustainable and cost-effective alternative to traditional chemical synthesis methods .
One of the main challenges in producing L-lactate using E. coli is balancing the competition between cell growth and lactate synthesis. The enzymatic properties, especially the thermodynamics of L-LDH, play a crucial role in regulating metabolic pathways and optimizing lactate production. Future research aims to further enhance the efficiency of L-lactate production by exploring new genetic modifications and optimizing fermentation processes .
In conclusion, the recombinant L-Lactate Dehydrogenase from E. coli represents a significant advancement in metabolic engineering, offering promising solutions for sustainable production of valuable biochemicals.